Sign inJoin waitlistJoin the waitlist

Andrew Brunner

Physician · Massachusetts General Hospital

Credentials: · · · ·

History

Massachusetts General Hospital
Present

Hematology and Medical Oncology
2013–2016
Internal Medicine
Massachusetts General Hospital
2010–2013
Warren Alpert Medical School of Brown University
2006–2010

Research

Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study
The Lancet Haematology · 2017 · 398 citations
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
Leukemia · 2021 · 169 citations
Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical Trial
JAMA Oncology · 2021 · 168 citations

Amir Fathi
72 papers
GH
Gabriela Hobbs
35 papers
Richard Stone
31 papers
PA
Philip Amrein
29 papers
RK
Rami Komrokji
28 papers
Amer Zeidan
26 papers
DS
David Steensma
26 papers
Mikkael Sekeres
24 papers
Robert Hasserjian
23 papers
AD
Amy DeZern
21 papers
Daniel DeAngelo
21 papers
Gail Roboz
20 papers

Clinical trials

MBG453 in Lower Risk MDS
Principal investigator · Terminated · Phase 2
Massachusetts General Hospital
2022–2025
AZD6738 for Patients With Progressive MDS or CMML
Principal investigator · Active not recruiting · Phase 1
Massachusetts General Hospital
2019–2026
Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia
Principal investigator · Completed · Phase 2
Massachusetts General Hospital
2017–2021
Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation
Principal investigator · Completed · Phase 1
Massachusetts General Hospital
2015–2024